News 
Contact Us
No. 18, Fuyuan Road, Tianjin Wuqing Development Area, China
Corporate Style | CHASE SUN Selected as one of the Top 30 Chinese Medicine Listed Companies in 2024
Corporate Style
Recently, the 2024 China Traditional Chinese Medicine Industry High Quality Development Conference and the 5th China Traditional Chinese Medicine Brand Building Conference were held in Suzhou. At the meeting, the China Association of Traditional Chinese Medicine released the 2024 Chinese Medicine Brand Report, and Tianjin Chase Sun Co., Ltd. (hereinafter referred to as "Chase Sun") was selected as one of the top 30 Chinese medicine listed companies in 2024.
The report on traditional Chinese medicine brands is organized by the China Association of Traditional Chinese Medicine. Based on the collection and research, it is generated through expert group evaluation, comprehensive group review, and office meeting approval in accordance with the Chinese Medicine Association's "Traditional Chinese Medicine Brand Evaluation" series of group standards. Among them, the selection of the top 30 Chinese medicine listed companies in 2024 focuses on three indicators: revenue, profit, and R&D investment, aiming to promote the growth and strength of Chinese medicine listed companies and promote the high-quality development of the Chinese medicine industry.
As one of the early six pilot enterprises approved by the state for traditional Chinese medicine formula granules, Chase Sun has always been guided by the theory of "full ingredient" traditional Chinese medicine formula granules, and has applied advanced technology in modern drug research and development to promote the high-quality development of the traditional Chinese medicine formula granule industry. Through continuous innovation and accumulation, Chase Sun has established core platforms such as the National Enterprise Technology Center, the National Local Joint Engineering Research Center for Key Technologies of Traditional Chinese Medicine Formula Granules, and the National Intangible Cultural Heritage (Traditional Chinese Medicine Processing) Inheritance Base. It continuously deepens the standardization and modernization research of traditional Chinese medicine formula granules, is committed to improving product quality and efficacy, and meets the needs of domestic and foreign markets. At the same time, actively expanding the international market, promoting the globalization process of traditional Chinese medicine formula granules, and providing more high-quality traditional Chinese medicine treatment solutions for patients worldwide.
Chase Sun's current business covers six major sectors: traditional Chinese medicine formula granules, finished drugs, raw materials, medical devices, medical and health services, and intelligent supply chain for pharmaceutical devices. Among them, Chase Sun's core product, Xuebijing Injection, which has independent intellectual property rights, is a representative drug for the treatment of severe pneumonia, sepsis, and multiple organ dysfunction syndrome. It has become a recommended medication for the treatment of severe and critical illnesses in traditional Chinese medicine and has been promoted to the world. Research has shown that Xuebijing can reduce the 28 day all-cause mortality rate of sepsis patients by 7.3%. This achievement has been recognized by the internationally authoritative journal JAMA Internal Medicine and is hailed as a high-quality 'Chinese solution'.
In addition, Chase Sun is also committed to the integration of traditional Chinese medicine and modern science and technology. Its "Shang Yi Ming Jia" is committed to building a trusted brand in the field of traditional Chinese medicine health. It provides customers with a full course of traditional Chinese medicine health services from physical chain hospitals, Internet hospitals, to the research and development of health products and health management. With the support of AI technology, traditional Chinese medicine diagnosis and treatment services are made more convenient, efficient, and personalized through wearable devices, mobile applications, and other tools. Patients and their families can also learn and master more traditional Chinese medicine health knowledge through online health classes, and actively manage their own health.
In the future, Chase Sun will lead by technological innovation, continuously deepen its brand power, product power, and service power, provide high-quality products and health services to the general public, and contribute the "Chase Sun Power" to promote a healthy China.
Source：Chase Sun
Release Time：2024-12-12 21:16:00
Home